About Technology Issues FAQ

Links

Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial

Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.